×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 4: Japan and Asia Updates
Session Chair(s)
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan
Japanese labels must be updated according to the new regulations, and necessary preparations for the potential impact of the new regulation on global labeling will be discussed. This session will also provide PMDA initiatives in Asia and updates on important labeling-related regulatory trends in Asia, including China, Singapore, Korea, and Vietnam.
Learning Objective : At the conclusion of this session, participants should be able to:- Describe the new labeling regulations for Japan and how to prepare for the revision
- Discuss the impact of the new labeling regulations for Japan on global labeling
- Discuss PMDA initiatives and regulatory trends related to labeling in Asia
Speaker(s)
New Labeling Regulations in Japan and PMDA Initiatives in Asia
Shinobu Uzu, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Senior Executive Director
Labeling in Asia: A Dynamic Landscape
Rie Matsui, RPh
Pfizer R&D Japan G.K., Japan
Senior Director, Regional Labeling Head for APAC, International Labeling
Panel Discussion
All Session Speakers, United States
Panel Q&A
United States